Drugs that contain Palonosetron Hydrochloride

1. List of Aloxi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9066980 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US8729094 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US9457020 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US8518981 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US9439854 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US7947725 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US8598218 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US9457021 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US9125905 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US7960424 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US9173942 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US7947724 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US8598219 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jan, 2024

(11 months from now)

US7947724

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US7947725

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US7960424

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US8518981

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US8598218

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9173942

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9439854

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9457020

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US8729094

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US8598219

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9125905

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9457021

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

US9066980

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron
Jul, 2024

(1 year, 5 months from now)

Market Authorisation Date: 25 July, 2003

Treatment: Prevention of chemotherapy-induced nausea and vomiting

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of ALOXI before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in